_____ (with M. Ward). "The vertical chain of research and development in the pharmaceutical industry." Economic Inquiry (January 1995).

_____ (with M. Stanley). "Cost reduction versus reputation enhancement as motives for mergers: The logic of multihospital systems." Strategic Management Journal (1995).

_____. Clinton's Specialist Quota: Shaky Premises, Questionable Consequences. (monograph), American Enterprise Institute (1994).

_____ (with P. Wehner). "Physician-induced demand for childbirths." Journal of Health Economics (Winter 1994).

_____. "A problem with consumer surplus measures of the cost of physician practice variations." Journal of Health Economics (Autumn 1994).

_____ (with D. Meltzer). "Do important drugs reach the market sooner?" Rand Journal of Economics (Autumn 1994).

_____ (with C. Olsen). "The economic side effects of dangerous drug announcements." Journal of Law and Economics (Fall 1994).

_____ (with W. White). "Doing a number on doctors." American Enterprise Magazine (July/August 1994).

_____ (with W. White). "Recent theory and evidence on hospital competition." Journal of Economics and Management Strategy (Spring 1994).

_____. "Can competition cut the mustard?" Health Management Quarterly (Spring 1994).

_____. "Local multi-hospital systems will be critical to the success of teaching and community hospitals." Compendium of Hospital Economics Newsletter (Fall 1994).

_____. "Measuring costs for cost-effectiveness analysis," chapter two in F. Sloan (ed.) Cost-effectiveness Analysis of Pharmaceuticals. Campidge: Campidge University Press (1994).

_____ (with W. White). "The changing nature of competition in health care." Journal of Medical Practice Management (Spring 1993).

_____ (with M. Shanley and W. White). "Price and concentration in hospital markets: The switch from patient-driven to payer-driven competition." Journal of Law and Economics (April 1993).

_____ (with W. White and L. Wu). "Segmentation in local hospital markets." Medical Care (January 1993).

_____. "The case for competition," in R. Arnold, R. Rich, and W. White (eds.) Competitive Approaches to Health Care Reform. Washington, DC: Urban Institute Press (1993).

_____. "The five W's of utilization review." American Health Policy. R. Helms (ed.). American Enterprise Institute (1992).

_____ (with M. Satterthwaite). "Monopolistic competition when price and quality are not perfectly observable." Rand Journal of Economics (Winter 1992).

_____ (with M. Shanley and C. Simon). ³Is hospital competition wasteful?² Rand Journal of Economics (Summer 1992).

Fernandez, Roberto (with R. V. Gould). "A dilemma of state power: pokerage and influence in the national health policy domain." American Journal of Sociology 99, 6 (1994): 1455-1491.

Lewis, Dan A. (with L. Grossman and others). "State psychiatric hospital patients with past arrests for violent crimes." Psychiatric Services 46, 8 (August 1995).

_____ (et al.). The State Mental Patient and Urban Life: Moving In and Out of the Institution. Springfield, IL: Charles C. Thomas (1994).

Weispod, Burton A. "The cycle of innovation," in National Heart, Lung, and Blood Institute Report of the Workshop on the Artificial Heart: Planning for Evolving Technologies (1994): 107-112.

_____. "The nature of technological change: Incentives matter!" in A. C. Gelijns and H. V. Dawkins (eds.) Institute of Medicine Medical Innovation at the Crossroads Adopting New Medical Technology 4. National Academy Press (1994): 8-48.

_____."Technologies, incentives, and health care costs: What is in our future?" in J. Andrade (ed.) Medical and Biological Engineering in the Future of Health Care. University of Utah Press (1994): 73-87.

_____.(with N. Wolff and E. Bird). "The supply of volunteer labor: The case of hospitals." Nonprofit Management and Leadership 4, 1 (1993): 23-45.

_____. "Economics of mental illness: Costs, benefits and incentives," in B. Jonson and J. Rosenbaum (eds.) The Health Economics of Depressions: The Cost of Disease and the Cost-effectiveness of Treatment. Perspectives in Psychiatry 4 (199x): 15-34.

_____. "Productivity and incentives in the medical care sector." The Scandinavian Journal of Economics 94 (1992): 131-145.

_____ (with D. Cleeton and V. Goepfrich). "The consumer price index for prescription drugs: Dealing with technological change." Health Care Financing Review (Spring 1992).